← All organizations
Istituto Nazionale Malattie Infettive Lazaro Spallanzani
Academic/Hospital
Also known as: INMI | IRCCS INMI Lazzaro Spallanzani - Istituto nazionale Malattie Infettive | Istituto Nazionale Malattie Infettive Lazaro Spallanzani | Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani | Istituto Nazionale per le Malattie Infettive "Lazzaro Spallanzani" IRCCS | Istituto per le Malattie Infettive Lazzaro Spallanzani IRCCS | National Institute for the Infectious Diseases (L. Spallanzani) - Rome | Societa' Italiana Di Malattie Infettive E Tropicali
Highest phase reached
Phase 3
First clinical trial
Feb 1, 2017Last known activity
Jun 6, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 7 trials)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT04952805Overall official - principal investigatorPhase 2/Phase 3Jun 6, 2021
- NCT04979468Lead sponsorPhase 3Mar 23, 2021
- NCT04791423CollaboratorPhase 2/Phase 3Mar 15, 2021
- NCT04791423Overall official - principal investigatorPhase 2/Phase 3Mar 15, 2021
- NCT04636671CollaboratorPhase 3Nov 25, 2020
- NCT04528641Overall official - principal investigatorPhase 1Aug 10, 2020
- NCT04528641CollaboratorPhase 1Aug 10, 2020
- NCT04120415CollaboratorPhase 2Nov 30, 2019
- NCT02972450CollaboratorPhase 2Feb 1, 2017
Details
- Last known activity
- Jun 6, 2021